5-vinyl-1-arabinofuranosyluracil: RN given refers to beta-(D)-isomer
ID Source | ID |
---|---|
PubMed CID | 126501 |
SCHEMBL ID | 1627679 |
MeSH ID | M0140037 |
Synonym |
---|
1-beta-d-arabinofuranosyl-5-vinyluracil |
1-[(2r,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-vinyl-pyrimidine-2,4-dione |
vinyl-ara-u |
varau |
1-[(2r,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-ethenylpyrimidine-2,4-dione |
74886-33-2 |
2,4(1h,3h)-pyrimidinedione, 1-beta-d-arabinofuranosyl-5-ethenyl- |
5-vinyl-1-arabinofuranosyluracil |
SCHEMBL1627679 |
5-ethenyl-4-hydroxy-1-pentofuranosylpyrimidin-2(1h)-one |
DTXSID90996382 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (85.71) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.21) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |